HSPB6 and urinary bladder carcinoma: Compared with the control group, the phosphorylation levels of PI3K, AKT, and mTOR were significantly reduced after HSPB6 overexpression, suggesting that HSPB6 inhibited the activation of PI3K/AKT/mTOR signaling pathway in bladder cancer.